In terms of mechanism, BMSCs may relieve FSGS by improving the imbalance of renal MMP/TIMP and suppressing the expression of renal inflammatory factors IL-6 and TNF-α. This evidence concerns the gene TIMP1 and focal segmental glomerulosclerosis.